tm logo
VOFICTO
REGISTERED

on 12 Jul 2019

Last Applicant/ Owned by

ASTELLAS PHARMA INC.

5-1, Nihonbashi-Honcho 2-chomeChuo-Ku, Tokyo

JP

Serial Number

1858849 filed on 21st Sep 2017

Registration Number

TMA1040502 registered on 12th Jul 2019

Registration expiry Date

12th Jul 2029

Correspondent Address

BROOKFIELD PLACE181 BAY STREET, SUITE 2100P.O. BOX 874TORONTO

ONTARIO

CA

M5J2T3

VOFICTO

Trademark usage description

pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of central nervo Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of central nervous system, namely, brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of genetic diseases and disorders, namely, enzyme deficiency; pharmaceutical preparations for the treatment of immunological diseases and disorders, namely, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of infectious diseases and disorders, namely, respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammatory diseases and disorders, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of menopausal diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of musculoskeletal diseases and disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, brain injury, spinal cord injury, seizure disorders, pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment of peripheral nervous system diseases and disorders, namely, convulsions and seizures; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of renal, respiratory, urogenital, urological, osteopathic, hematological and pulmonary diseases and disorders and pharmaceutical preparations for the treatment of viral diseases and disorders, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment pain and diabetes; pharmaceutical preparations for use in regenerative medicine, namely the use of platelet rich plasma stem cells and scaffolds for the treatment of injuries and degeneration of joints; pharmaceutical preparations, namely, antibacterial preparations, antifungal preparations, antiviral preparations, dermatological preparations, immunosuppressants, and tissue repair preparations; human vaccines


Classification kind code

11

Mark Details


Serial Number

1858849

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 24th May 2019
Allowed
Submitted for opposition 42
on 06th Feb 2019
Advertised
Submitted for opposition 26
on 17th Jan 2019
Approved
Submitted for opposition 27
on 29th Nov 2018
Approval Notice Sent
Submitted for opposition 15
on 24th Oct 2018
Correspondence Created
Submitted for opposition 22
on 21st Sep 2018
Search Recorded
Submitted for opposition 20
on 21st Sep 2018
Examiner's First Report
Submitted for opposition 31
on 25th Sep 2017
Formalized
Submitted for opposition 1
on 22nd Sep 2017
Created
Submitted for opposition 30
on 21st Sep 2017
Filed